Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication\nin end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patientcentered,\npharmacistâ??dietician-led approach to managing CKD-MBD was developed. The purpose of\nthis study was to evaluate if the new approach impacted serum markers of CKD-MBD and medication\nburden, and to evaluate patient satisfaction. A single-arm, preâ??post, mixed-methods study was conducted.\nSerum markers of CKD-MBD and medication data were collected pre- and post-intervention, and a\npatient survey administered post-intervention. Focus groups were conducted, transcribed, and analyzed\nthematically. No statistically significant differences in serum markers of CKD-MBD or medication burden\nwere found. Eighty-seven percent of patients were satisfied with their care, however, 31% were very\ndissatisfied with medical explanations provided to them and 48% felt their allotted time with healthcare\nprofessionals was too short. Four major themes identified from focus groups included lack of privacy,\nknowledge and perceptions of blood work rounds, issues with taking phosphate binders, and areas for\nincreased patient education. Patients would prefer more information regarding their blood work results\nand more time with the healthcare team. Areas for expanded education include renal diet, phosphate\nbinders, and consequences of abnormal bloodwork.
Loading....